Market Research Reports and Industry Reports

Therapeutic Class Report Overview : Hepatitis C Virus Infection

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION
The launch of Protease inhibitors (PIs) created a wave in 2011-12 and accelerated the pace of innovation and impressive Sustained Virologic Response (SVR) rates by oral IFN free drug combinations have raised the bar and the expectations of pts, physicians and investors. Freedom from IFN, treating all genotypes and betting on vaccines could bring a sea of change in the HCV therapy class area in the future.

Roche set the trend with the acquisition of Anadys for total of $230m followed by GILD buying VRUS for $11b, Bristol-Myers Squibb (BMY) acquired Inhibitex for $2.5b, VRTX acquired Virochem in 2009 for $375m + in-licensed Alios VX-135 in 2012 for total of $775m, and Abbott in-licensed Enantas ABT-450 for total of ~$310m. In the next spurt of M&A in this sector, we expect companies which offer differentiated MOA to be in the limelight, are (i) Alleviate the need for Ribavarin, (ii) Address resistance, non-responders, Liver cirrhosis, HIV-HCV co infection etc, (iii) Target other genotypes, and (iv) Vaccines or Boosters of immune system (toll like receptors). In this report, we have analyzed the novel pipeline candidates, which target unmet needs, offer promise of an all oral IFN-free treatment with at par or better efficacy / compliance, and novel vaccine candidates.
N/A

List Of Tables

N/A

List Of Figures

N/A

China Therapeutic Ultrasound Devices Market Research Report 2017

Notes:Sales, means the sales volume of Therapeutic Ultrasound DevicesRevenue, means the sales value of Therapeutic Ultrasound DevicesThis report studies Therapeutic Ultrasound Devices in China market, focuses on the top players

USD 3200View Report

United States Leukemia Therapeutics Market Report 2017

Notes:Sales, means the sales volume of Leukemia TherapeuticsRevenue, means the sales value of Leukemia TherapeuticsThis report studies sales (consumption) of Leukemia Therapeutics in United States market, focuses on the top

USD 3800View Report

United States Chronic Lymphocytic Leukemia (CLL) Therapeutics Devices Market Report 2017

Notes:Sales, means the sales volume of Chronic Lymphocytic Leukemia (CLL) Therapeutics DevicesRevenue, means the sales value of Chronic Lymphocytic Leukemia (CLL) Therapeutics DevicesThis report studies sales (consumption) of Chronic Lymphocytic

USD 3800View Report

Therapeutic Class Report Overview - Future Of GPR Agonist

Despite about half a dozen distinct targets having been innovated and introduced in the market for the oral treatment of Type 2 diabetes, ~60% of diabetics still exhibit progressive worsening

USD 1000View Report

Therapeutic Class Report Overview - Japan Biosimilars

200b worth of biologic products is going off patent by 2015 and this value exceeds ~ 500b if we include products that will see their patent expiries by 2021 in

USD 1000View Report

Therapeutic Class Report Overview - Hemophilia

Hemophilia is an inherited (X-linked recessive trait), lifelong bleeding disorder that prevents blood from clotting due to insufficient or lack of adequate amount of clotting factors Factor VIII (FVIII)

USD 2000View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
Country Code.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 1000
  • Site Licence    $ 2000
  • Enterprisewide Licence    $ 3000
$ 1000

Reports Details

Published Date : Feb 2013
No. of Pages :31
Country :Global
Category :Healthcare
Publisher :MP Advisors
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment